scutellarin has been researched along with Inflammation in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 8 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, X; Guo, J; Hu, S; Jiang, S; Lan, T; Li, H; Luo, D; Piao, S; Rong, X; Tian, S; Wang, L; Wang, W; Weng, Q; Xiao, X; Yang, Y; Yu, Y; Zhang, J; Zhu, Q | 1 |
| Liu, YC; Meng, YX; Wang, LL; Wang, SS; Wang, YF; Xie, SS; Zhang, XY | 1 |
| Chen, F; Chen, ZQ; Huang, JW; Li, HL; Li, L; Li, T; Zheng, J; Zhou, Y | 1 |
| Dai, Y; He, Q; Liu, Y; Wen, PH; Zhang, XX | 1 |
| Aini, M; Cai, R; Gao, Z; Huo, Y; Mijiti, A; Qie, R; Wang, Z | 1 |
| An, H; Huang, Y; Lv, S; Peng, D; Shao, W; Wang, L; Wang, Y; Wei, D; Zhang, S; Zhang, Z | 1 |
| Bello, BK; Chen, H; Chen, Y; Dong, J; Fan, H; Feng, X; Liu, G; Teng, D; Wang, Y; Yang, Q; Zhang, X; Zhao, P | 1 |
| Dong, J; Dong, Z; Fan, H; Fu, M; He, N; Li, X; Pan, E; Yang, Q; Yu, G; Zhang, X; Zhao, P | 1 |
| Gao, F; Hu, CP; Huang, B; Meng, J; Peng, L; Shi, QF; Wang, CM; Wen, L | 1 |
| Baluchnejadmojarad, T; Roghani, M; Zeinali, H | 1 |
| Li, JJ; Ling, EA; Liu, SJ; Liu, XY | 1 |
| Feng, B; Nie, J; Su, ZQ; Sun, CY; Wu, LM; Zhao, J; Zheng, GJ; Zheng, ZL; Zhu, Y | 1 |
| Fang, M; Ling, EA; Wu, CY; Yuan, Y | 1 |
| Liu, X; Luo, P; Mo, Z; Yi, T; Zhang, H; Zhang, Z | 1 |
2 review(s) available for scutellarin and Inflammation
| Article | Year |
|---|---|
Herbal Compounds with Special Reference to Gastrodin as Potential Therapeutic Agents for Microglia Mediated Neuroinflammation.
Topics: Apigenin; Benzyl Alcohols; Glucosides; Glucuronates; Humans; Inflammation; Isoflavones; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Plants, Medicinal; Renin-Angiotensin System | 2018 |
Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia.
Topics: Apigenin; Brain Ischemia; Drugs, Chinese Herbal; Glucuronates; Humans; Inflammation; Microglia; Signal Transduction | 2016 |
12 other study(ies) available for scutellarin and Inflammation
| Article | Year |
|---|---|
Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.
Topics: Animals; Diet, High-Fat; Flavonoids; Inflammation; Lipid Metabolism; Liver; Liver Cirrhosis; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease | 2022 |
[Protective effect of breviscapine against brain injury induced by intrauterine inflammation in preterm rats and its mechanism].
Topics: Animals; Body Weight; Brain Injuries; Caspase 1; Female; Flavonoids; Inflammation; Interleukin-6; Interleukin-8; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Pregnancy; Rats | 2023 |
Breviscapine Pretreatment Inhibits Myocardial Inflammation and Apoptosis in Rats After Coronary Microembolization by Activating the PI3K/Akt/GSK-3β Signaling Pathway.
Topics: Administration, Oral; Animals; Apoptosis; Coronary Vessels; Dose-Response Relationship, Drug; Flavonoids; Glycogen Synthase Kinase 3 beta; Inflammation; Male; Molecular Structure; Myocardial Infarction; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Structure-Activity Relationship | 2021 |
Breviscapine ameliorates CCl4‑induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Carbon Tetrachloride; Cell Line; Chemical and Drug Induced Liver Injury; Cytokines; Flavonoids; Humans; Inflammation; Liver; Male; Mice, Inbred C57BL; Rats; Reactive Oxygen Species | 2018 |
Scutellarin alleviates type 2 diabetes (HFD/low dose STZ)-induced cardiac injury through modulation of oxidative stress, inflammation, apoptosis and fibrosis in mice.
Topics: Animals; Apigenin; Apoptosis; Biomarkers; Blood Glucose; Body Weight; Cardiovascular Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucuronates; Heart Diseases; Inflammation; Lipids; Male; Mice; Oxidative Stress; RNA, Messenger | 2021 |
Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apigenin; Brain-Gut Axis; Cognitive Dysfunction; Disease Models, Animal; Gastrointestinal Microbiome; Glucuronates; Histones; Inflammation; Interleukin-1beta; Mice; Mice, Transgenic; Presenilin-1 | 2022 |
Protective Activities of Scutellarin against Alcohol-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Antioxidants; Apigenin; Ethanol; Humans; Inflammation; Oxidative Stress | 2022 |
Scutellarin prevents acute alcohol-induced liver injury via inhibiting oxidative stress by regulating the Nrf2/HO-1 pathway and inhibiting inflammation by regulating the AKT, p38 MAPK/NF-κB pathways.
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Ethanol; Heme Oxygenase-1; Inflammation; Liver; Male; Mice; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Necrosis Factor-alpha | 2023 |
Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation.
Topics: Animals; Apigenin; Epithelial-Mesenchymal Transition; Glucuronates; Inflammation; Male; Mice; NF-kappa B; Pulmonary Fibrosis; Transfection | 2020 |
Scutellarin alleviates lipopolysaccharide-induced cognitive deficits in the rat: Insights into underlying mechanisms.
Topics: Animals; Apigenin; Cognitive Dysfunction; Glucuronates; Hippocampus; Inflammation; Interleukin-6; Lipopolysaccharides; Male; Malondialdehyde; Neuroprotective Agents; NF-kappa B; Rats; Rats, Wistar; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2018 |
Renoprotective effect of scutellarin on cisplatin-induced renal injury in mice: Impact on inflammation, apoptosis, and autophagy.
Topics: Acute Kidney Injury; Animals; Apigenin; Apoptosis; Autophagy; Cisplatin; Glucuronates; Inflammation; Male; Mice; Mice, Inbred C57BL; Protective Agents; Random Allocation | 2019 |
Anti-inflammatory activity of the extracts and fractions from Erigeron multiradiatus through bioassay-guided procedures.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Biological Assay; Disease Models, Animal; Edema; Erigeron; Female; Flavonoids; Glucuronates; Inflammation; Male; Medicine, Tibetan Traditional; Mice; Plant Extracts; Rats; Rats, Sprague-Dawley; Tibet | 2008 |